Benzinga··Vandana SinghNexGel to Triple Revenue With Celularity Biomaterial Portfolio Acquisition
NexGel acquires regenerative biomaterial portfolio from Celularity, expecting to nearly triple 2026 revenue to $35M and achieve immediate profitability.
NXGLNXGLWCELUCELUWacquisitionprofitability